The 42 references in paper Vasiliy Bryukhov Valerevich, Sofya Kulikova Nikolaevna, Irina Krotenkova Andreevna, Marina Krotenkova Viktorovna, Anastasia Peresedova Vyacheslavovna, Василий Брюхов Валерьевич, Софья Куликова Николаевна, Ирина Кротенкова Андреевна, Марина Кротенкова Викторовна, Анастасия Переседова Вячеславовна (2014) “МРТ в диагностике рассеянного склероза // Magnetic Resonance Imaging in Multiple Sclerosis” / spz:neicon:medvis:y:2014:i:2:p:10-21

1
Storch-Hagenlocher B., Bendszus M. Multiple Sclerosis. Inflammatory diseases of the brain. S. Hahnel, ed. Berlin; Heidelberg: Springer-Verlag, 2009. 236 p.
(check this in PDF content)
2
Гусев Е.И., Бойко А.Н., Силуянова В.А. и др. Варианты течения и прогноз при рассеянном склерозе. Рассеянный склероз и другие демиелинизирующие заболевания: Руководство для врачей; Под ред. Гусева Е.И., Бойко А.Н., Завалишина И.А. М.: Миклош, 2004. 158–180.
(check this in PDF content)
3
Young I.R., Hall A.S., Pallis C.A. et al. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet, 1981; 14; 2 (8255): 1063–1066.
(check this in PDF content)
4
McDonald W.I., Compston A., Edan G. et al. Recommended diagnostic criteria for multiple sclerosis: from the International Panel on the Diagnosis of Multiple Sclerosis. Ann. Neurol. 2001; 50: 121–127.
(check this in PDF content)
5
Polman C.H., Reingold S.C., Edan G. et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Neurology. 2005; 58: 840–846.
(check this in PDF content)
6
Montalban X., Tintore M., Swanton J. et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology. 2010; 74: 427–434.
(check this in PDF content)
7
Кротенкова М.В., Кугоев А.И., Коновалов Р.Н. и др. Магнитно-резонансная томография при рассеянном склерозе. Мед. виз. 2001; 1: 62–66.
(check this in PDF content)
8
Fazekas F., Barkhof F., Filippi M. et al. The contribution of magnetic resonance imaging to diagnosis of multiple sclerosis. Neurology. 1999; 53 (3): 448–456.
(check this in PDF content)
9
Simon J.H., Holtas S.L., Shiffer R.B. et al. Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis detection with MR. Radiology. 1986; 160: 363–367.
(check this in PDF content)
10
Filippi M., Miller D.H. MRI in the differential diagnosis and monitoring the treatment of multiple sclerosis. Curr. Opin. Neurol. 1996; 9: 178–186.
(check this in PDF content)
11
Hashemi R.H., Bradley W.G., Chen D.Y. et al. Suspected multiple sclerosis: MR imaging with a thin-section fast FLAIR pulse-sequence. Radiology. 1995; 196: 505–510. Рис. 9.МР-изображения головного мозга (собственное наблюдение). а – в режиме Т2-FLAIR-ВИ, аксиальная проекция; б – в режиме Т2ВИ, аксиальная проекция; в – в режиме Т1ВИ после внутривенного введения КВ, аксиальная проекция. В белом веществе правого полушария большого мозга на фоне типичных очагов демиелинизации визуализируется очаг неоднородной структуры, напоминающий годичные кольца на спиле дерева (по типу Бало). 01_010-021_Bryukhov (12).qxd 5/3/2014 4:05 PM Page 18
(check this in PDF content)
12
Gasperini C., Horsfield M.A., Thorpe J.W. et al. Macroscopic andmicroscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parameters. J. Magn. Reson. Imaging. 1996; 6: 580–584.
(check this in PDF content)
13
Zhao G.J., Li D.K.B., Cheng Y. et al. Active multiple sclerosis lesions occur in dirty-appearing white matter as detected by serial magnetic resonance imaging. Ann. Neurol. 1998; 44: 465.
(check this in PDF content)
14
Waesberghe J.H.T.M., van Walderveen M.A.A., Castelijns J.A. et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1weighted spin-echo and magnetization MR. Am. J. Neuroradiol. 1998; 19: 675–683.
(check this in PDF content)
15
Walderveen M.A.A., Kamphorst W., Scheltens P. et al. Correlate of hypointense lesions on T1-weighted spinecho MRI in multiple sclerosis. Neurology. 1998; 50: 1282–1288.
(check this in PDF content)
16
Waesberghe J.H., Castelijns J.A., Scheltens P. et al. Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis. J. Magn. Reson. Imaging. 1997; 15: 155–162.
(check this in PDF content)
17
Gass A., Filippi M., Rodegher M.E. et al. Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1-weighted MRI. Neurology. 1998; 50: 548–550.
(check this in PDF content)
18
Fazekas F., Barkhof F., Filippi M. et al. The contribution of magnetic resonance imaging to diagnosis of multiple sclerosis. Neurology. 1999; 53 (3): 448–456.
(check this in PDF content)
19
Offenbacher H., Fazekas F., Schmidt R. et al. Assessment of MRI criteria for a diagnosis of MS. Neurology. 1993; 43: 905–909.
(check this in PDF content)
20
Ge Y., Law M., Herbert J. et al. Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination. Am. J. Neuroradiol. 2005; 26: 2316–2319.
(check this in PDF content)
21
Miller D.H., Barkhof F., Frank J.A. et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain. 2002; 125: 1676–1695.
(check this in PDF content)
22
Dietemann J.L., Beigelman C., Rumbach L. et al. Multiple sclerosis and corpus callosum atrophy: relationship of MRI findings to clinical data. Neuroradiology. 1988; 30: 478–480.
(check this in PDF content)
23
Stefano N., Airas L., Grigoriadis N. et al. Clinical relevance of brain volume measures in multiple sclerosis. CNS Drugs. 2014; 28 (2): 147–156.
(check this in PDF content)
24
Brex P.A., Jenkins R., Fox N.C. et al. Detection of ventricular enlargement in patients at the earliest clinical stage of MS. Neurology. 2000; 54: 1689–1691.
(check this in PDF content)
25
Ge Y., Grossman R.I., Babb J.S. et al. Age-related total gray matter and white matter changes in normal adult brain. Part II. Quantitative magnetization transfer ratio histogram analysis. Am. J. Neuroradiol. 2002; 23: 1334–1341.
(check this in PDF content)
26
Sastre-Garriga J., Ingle G.T., Chard D.T. et al. Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. Brain. 2005; 128: 1454–1460.
(check this in PDF content)
27
Khoury S., Bakshi R. Cerebral pseudoatrophy or real atrophy after therapy in multiple sclerosis. Ann. Neurol. 2010; 68 (6): 778–779.
(check this in PDF content)
28
Lycklama а Nijeholt G.J., van Walderveen M.A., Castelijns J.A. et al. Brain and spinal cord abnormalities in multiple sclerosis: correlation between MRI parameters, clinical subtypes and symptoms. Brain. 1998; 121: 687–697.
(check this in PDF content)
29
Tartaglino L.M., Friedman D.P., Flanders A.E. et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology. 1995; 195: 725–732.
(check this in PDF content)
30
Nelson F., Poonawalla A.H., Hou P. et al. Improved visualization of intracortical lesions in multiple sclerosis by phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. Presented at the 22nd Congress of the European Committee for the Treatment and Research in Multiple Sclerosis. Madrid, September 27–30, 2006. 639.
(check this in PDF content)
31
Куликова С.Н., Китаев С.В., Брюхов В.В., Кротенкова М.В. Особенности визуализации спинного мозга при рассеянном склерозе: традиционные МРТ-последовательности и роль модифицированной последовательности STIR (STIR*). Луч. диагн. и тер. 2011; 4 (2): 51–58.
(check this in PDF content)
32
Simon J.H. Contrast-enhanced MR imaging in the evaluation of treatment response and prediction of outcome in multiple sclerosis. J. Magn. Reson. Imaging. 1997; 7: 29–37.
(check this in PDF content)
33
Nesbit G.M., Forbes G.S., Sheithauter B.W. et al. Histopathiologic and MR and CT correlation in 37 cases at biopsy and 3 cases at autopsy. Radiology. 1991; 180: 467–474.
(check this in PDF content)
34
Barkhof F., Bruck W., De Groot C.J. et al. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch. Neurol. 2003; 60: 1073–1081.
(check this in PDF content)
35
He J., Grossman R.I., Ge Y. et al. Enhancing patterns in multiple sclerosis: evolution and persistence. Am. J. Neuroradiol. 2001; 22: 664–669.
(check this in PDF content)
36
Dousset V., Grossman R.I., Ramer K.N. et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology. 1992; 182: 483–491.
(check this in PDF content)
37
Bardin T., Richette P. Nephrogenic systemic fibrosis. Curr. Opin. Rheumotal. 2010; 22: 54–58.
(check this in PDF content)
38
Eissa A., Lebel R.M., Korzan J.R. et al. Detecting lesions in multiple sclerosis at 4.7 tesla using phase SWI and T2. J. Magn. Reson. Imaging. 2009; 30: 737–742.
(check this in PDF content)
39
Suzuki M., Kudo K., Sasaki M et al. Detection of acute plaques in multiple sclerosis using SWI: comparison with gadolinium-enhanced MRI. Magn. Reson. Med. Sci. 2011; 10 (3): 185–192.
(check this in PDF content)
40
Thorpe J.W., Kidd D., Moseley I.F. et al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain. 1996; 119: 709–714.
(check this in PDF content)
41
Yao D.L., Webster H.D., Hudson L.D. et al. Concentric sclerosis (Balo): morphometric and in situ hybridization study of lesions in six patients. Ann. Neurol. Sci. 2004; 218: 73–77.
(check this in PDF content)
42
Scott W. Magnetic resonance imaging of brain and spine. 3rded. Philadelphia: Lippincot Williams & Wilkins, 2002. 1955 p.
(check this in PDF content)